SNDX FY2025 SEC EDGAR DEF 14A #128 of 168 in industry

Syndax Pharmaceuticals Inc CEO pay ratio

The CEO earned $7.3M in FY2025 against median worker pay of $383,252 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-30
Industry
Chemicals & Pharmaceuticals
Industry rank
#128/168

Data updated August 2026

Subscribe to Syndax Pharmaceuticals Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
19:1
Below Average (Scale: 0–1000:1)
CEO pay
$7.3M
Median worker
$383,252

Answer first

Syndax Pharmaceuticals Inc's FY2025 CEO total of $7.3M ranks #745 of 1,423 complete filings; its 19:1 pay ratio ranks #1219. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $383,252. Industry placement uses the FY2025 SIC-28 peer cohort (# 128 of 168, 24th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#745
$7.3M of 1,423 FY2025
Ratio rank
#1219
19:1 of 1,423
Industry pct
24th
among the lower quartile of industry peers by pay ratio

How Syndax Pharmaceuticals Inc ranks nationally

Syndax Pharmaceuticals Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$7,281,788 48th percentile higher than 48% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Syndax Pharmaceuticals Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($7.3M) against pay ratio (19:1) for Syndax Pharmaceuticals Inc (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02069624.94139249.76208874.68278499.516.8:123.4:130:136.6:143.2:1CEO total payPay ratio (CEO : median worker)Syndax Pharmaceuticals Inc, CEO total pay: 7281788 · Pay ratio (CEO : median worker): 19:1Syndax Pharmaceuticals IncuniQure N.V., CEO total pay: 3287434 · Pay ratio (CEO : median worker): 19:1uniQure N.V.Rogers Corp, CEO total pay: 4863589 · Pay ratio (CEO : median worker): 19:1Rogers CorpAgios Pharmaceuticals, Inc., CEO total pay: 5456520 · Pay ratio (CEO : median worker): 18:1Agios Pharmaceuticals, Inc.Aurinia Pharmaceuticals Inc., CEO total pay: 320246 · Pay ratio (CEO : median worker): 18:1Aurinia Pharmaceuticals Inc.Arvinas, Inc., CEO total pay: 327724 · Pay ratio (CEO : median worker): 20:1Arvinas, Inc.
Syndax Pharmaceuticals Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Syndax Pharmaceuticals Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Syndax Pharmaceuticals Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
19:1
FY2025
vs prior FY
-3:1
from FY2024 22:1
CEO $ YoY
-6.3%
$7.3M latest
Filings shown
4
FY2022–2025
Syndax Pharmaceuticals Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $4.1M - $316,414 13:1 -
2023 $9.1M +122% $364,766 25:1 +12:1
2024 $7.8M -15% $353,274 22:1 -3:1
2025 $7.3M -6.3% $383,252 19:1 -3:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1395937, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
19:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$7.3M
Companies in Industry
168
vs. Industry Median
Below
#128 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Syndax Pharmaceuticals Inc: near-parity Item 402(u) ratio

Syndax Pharmaceuticals Inc's FY2025 ratio 19:1 ranks #128 of 168 Chemicals & Pharmaceuticals filers (24th percentile). the CEO earned 19× the median employee ($383,252) in FY2025.

At $383,252 median worker pay, the FLOOR stamp is near pay-parity territory under HEAVY CEO total.

CEO Total Pay

$7.3M

FY2025 Summary Compensation, near median

Pay Ratio

19:1

Below typical

Syndax Pharmaceuticals Inc in the lower Chemicals & Pharmaceuticals third

Syndax Pharmaceuticals Inc's FY2025 ratio 19:1 ranks #128 of 168 Chemicals & Pharmaceuticals filers (24th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Syndax Pharmaceuticals Inc's $7.3M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #745 and ratio rank #1219 split - treat 19:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$7.3M
Median Employee Pay
$383,252
Pay Ratio
19:1
Filing Date
2026-04-30

Company Info

Ticker
SNDX
CIK
1395937
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1395937, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Syndax Pharmaceuticals Inc's FY2025 ratio 19:1 ranks #128 of 168 Chemicals & Pharmaceuticals filers (24th percentile).

Read with Syndax Pharmaceuticals Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · HEAVY · ELITE-MED.

Terex Corp · HEAVY

ABS(ceo_total_comp) peer at $7.3M (Δ $4K heavier vs Syndax Pharmaceuticals Inc); MID · PAR-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Gulfport Energy Corp · HEAVY

ABS(ceo_total_comp) peer at $7.3M (Δ $13K lighter vs Syndax Pharmaceuticals Inc); MODEST · ELITE-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Parsons Corp · HEAVY

ABS(ceo_total_comp) peer at $7.3M (Δ $15K lighter vs Syndax Pharmaceuticals Inc); MODEST · ELITE-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Hexcel Corp /de/ · HEAVY

ABS(ceo_total_comp) peer at $7.3M (Δ $29K lighter vs Syndax Pharmaceuticals Inc); MID · HIGH-MED vs this page's FLOOR · HEAVY · ELITE-MED.
uniQure N.V. (SIC 28 pole)

uniQure N.V. stamps FLOOR · MID$ nearest in-SIC by ABS(pay_ratio) to Syndax Pharmaceuticals Inc's FLOOR filing.
National dual ranks · #745/#1219

Syndax Pharmaceuticals Inc's FY2025 package sits #745 by CEO dollars and #1219 by ratio under HEAVY · FLOOR.
Ratio primer · FLOOR

Syndax Pharmaceuticals Inc's FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Syndax Pharmaceuticals Inc (CIK 1395937), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.